J. Gill

Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.

R. Heel, A. Fitton, J. Gill, 1992, Drugs.

A heparin-controlled study of MK-383 in unstable angina

F. Werf, C. Nienaber, P. Théroux, 1994 .

Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.

S. Yusuf, J. Pogue, M. Flather, 2000, European heart journal.

Saquinavir Soft Gelatin Capsule

J. Feinberg, J. Gill, 2001, Drug safety.

Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study.

J. Cairns, J. Hirsh, M. Gent, 1996, Circulation.

The Pathophysiology and Epidemiology of Myocardial Infarction

J. Gill, 2012, Drugs.

Dofetilide: first of a new generation of class III agents.

J. Gill, K. Ward, Kevin J Ward, 1997, Expert opinion on investigational drugs.